Search

everythinglearnresearchcommunity

for

Search:↓

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Hair loss may indicate higher risk of heart disease.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Minoxidil reduces lysine hydroxylase in skin cells.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Minoxidil lowers blood pressure and causes hair growth, with some side effects.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

Sex-determining genes may affect male baldness.

Women treated with X-ray for scalp fungus as children had a higher chance of hair loss, especially with higher radiation doses and severe fungus infections.

Using more minoxidil solution can lead to better hair growth, but people often use only half the recommended amount. Education and motivation can improve results.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The document summarizes skin and immune system disease findings, especially related to AIDS, from the 1980s.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Newly made nicotinamide compounds could potentially treat cancer.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.